Identification of human CD4+ T cell populations with distinct antitumor activity

Michelle H. Nelson†1,2, Hannah M. Knochelmann†1,2, Stefanie R. Bailey1,2, Logan W. Huff1,2, 4 Jacob S. Bowers1,2, Kinga Majchrzak1,2, Megan M. Wyatt1,2, Mark P. Rubinstein1,3, Shikhar 5 Mehrotra1,3, Michael I. Nishimura4, Kent E. Armeson5, Paul G. Giresi6, Michael J. Zilliox7, Hal 6 E. Broxmeyer8, Chrystal M. Paulos1,2*; †Contributed equally to this work *Corresponding author; Affiliations: 1Department of Microbiology & Immunology, Medical University of South Carolina, Charleston, SC, USA. 2Department of Dermatology & Dermatologic Surgery, Medical University of South Carolina, SC, USA. 3Department of Surgery, Medical University of South Carolina, Charleston, SC, USA. 4Department of Surgery, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA. 5Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA. 6Epinomics, Menlo Park, CA, USA. 7Department of Public Health Sciences, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA. 8Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.